2021 Q2 Form 10-Q Financial Statement

#000162828021016607 Filed on August 11, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $34.20M $16.66M
YoY Change 105.32% -77.91%
Cost Of Revenue $11.77M $10.60M
YoY Change 11.0% -65.81%
Gross Profit $22.43M $6.100M
YoY Change 267.7% -86.26%
Gross Profit Margin 65.59% 36.63%
Selling, General & Admin $2.522M $4.300M
YoY Change -41.35% -57.43%
% of Gross Profit 11.24% 70.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.667M $15.10M
YoY Change -75.72% -64.39%
% of Gross Profit 16.35% 247.54%
Operating Expenses $6.125M $19.40M
YoY Change -68.43% -62.98%
Operating Profit $16.05M -$215.4M
YoY Change -107.45% 1615.4%
Interest Expense -$84.00K $1.800M
YoY Change -104.67% -357.14%
% of Operating Profit -0.52%
Other Income/Expense, Net $203.0K -$389.0K
YoY Change -152.19% -46.57%
Pretax Income $16.25M -$215.8M
YoY Change -107.53% 1522.56%
Income Tax $0.00 $4.000K
% Of Pretax Income 0.0%
Net Earnings $16.25M -$215.8M
YoY Change -107.53% 1524.35%
Net Earnings / Revenue 47.53% -1295.58%
Basic Earnings Per Share $0.45 -$6.06
Diluted Earnings Per Share $0.44 -$6.06
COMMON SHARES
Basic Shares Outstanding 36.42M shares 35.61M shares
Diluted Shares Outstanding 37.35M shares 35.61M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $88.34M $13.50M
YoY Change 554.36% 73.08%
Cash & Equivalents $88.34M $13.47M
Short-Term Investments
Other Short-Term Assets $80.00K $80.00K
YoY Change 0.0% -67.61%
Inventory
Prepaid Expenses $2.186M $2.218M
Receivables $20.68M $16.61M
Other Receivables $0.00 $0.00
Total Short-Term Assets $113.6M $71.28M
YoY Change 59.3% 11.4%
LONG-TERM ASSETS
Property, Plant & Equipment $99.57M $106.7M
YoY Change -6.65% -46.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $594.0K $766.0K
YoY Change -22.45% -48.93%
Total Long-Term Assets $182.9M $284.1M
YoY Change -35.64% -71.09%
TOTAL ASSETS
Total Short-Term Assets $113.6M $71.28M
Total Long-Term Assets $182.9M $284.1M
Total Assets $296.4M $355.4M
YoY Change -16.6% -66.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $35.20M $29.90M
YoY Change 17.73% -61.22%
Accrued Expenses $3.051M $5.800M
YoY Change -47.4% -51.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $59.00M
YoY Change
Total Short-Term Liabilities $59.24M $124.6M
YoY Change -52.44% 11.32%
LONG-TERM LIABILITIES
Long-Term Debt $20.00M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.439M $3.209M
YoY Change -55.16% -30.04%
Total Long-Term Liabilities $21.44M $3.209M
YoY Change 568.09% -94.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.24M $124.6M
Total Long-Term Liabilities $21.44M $3.209M
Total Liabilities $116.9M $180.7M
YoY Change -35.31% -15.84%
SHAREHOLDERS EQUITY
Retained Earnings -$971.4M -$973.8M
YoY Change -0.25% 209.53%
Common Stock $37.00K $36.00K
YoY Change 2.78% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $179.6M $174.8M
YoY Change
Total Liabilities & Shareholders Equity $296.4M $355.4M
YoY Change -16.6% -66.05%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $16.25M -$215.8M
YoY Change -107.53% 1524.35%
Depreciation, Depletion And Amortization $3.667M $15.10M
YoY Change -75.72% -64.39%
Cash From Operating Activities $18.93M -$4.600M
YoY Change -511.54% -114.89%
INVESTING ACTIVITIES
Capital Expenditures -$4.793M -$1.300M
YoY Change 268.69% -97.88%
Acquisitions
YoY Change
Other Investing Activities $700.0K $500.0K
YoY Change 40.0% 25.0%
Cash From Investing Activities -$4.193M -$800.0K
YoY Change 424.13% -98.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -595.0K 12.70M
YoY Change -104.69% -58.5%
NET CHANGE
Cash From Operating Activities 18.93M -4.600M
Cash From Investing Activities -4.193M -800.0K
Cash From Financing Activities -595.0K 12.70M
Net Change In Cash 14.14M 7.300M
YoY Change 93.74% 1360.0%
FREE CASH FLOW
Cash From Operating Activities $18.93M -$4.600M
Capital Expenditures -$4.793M -$1.300M
Free Cash Flow $23.72M -$3.300M
YoY Change -818.91% -103.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8084793
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001349436
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33784
dei Entity Registrant Name
EntityRegistrantName
SANDRIDGE ENERGY, INC.
dei Entity Address Address Line1
EntityAddressAddressLine1
1 E. Sheridan Ave, Suite 500
dei Entity Address City Or Town
EntityAddressCityOrTown
Oklahoma City
dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
73104
dei City Area Code
CityAreaCode
405
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36588775 shares
dei Local Phone Number
LocalPhoneNumber
429-5500
dei Security12b Title
Security12bTitle
Common Stock, $.001 par value
dei Trading Symbol
TradingSymbol
SD
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Bankruptcy Proceedings Reporting Current
EntityBankruptcyProceedingsReportingCurrent
true
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88338000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22130000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2271000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
6136000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20681000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19576000 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2186000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2890000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
80000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
80000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
113556000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
50812000 USD
CY2021Q2 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1439904000 USD
CY2020Q4 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1463950000 USD
CY2021Q2 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
13365000 USD
CY2020Q4 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
17964000 USD
CY2021Q2 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
1370544000 USD
CY2020Q4 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
1375692000 USD
CY2021Q2 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
82725000 USD
CY2020Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
106222000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
99572000 USD
CY2020Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
40701000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
594000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
680000 USD
CY2021Q2 us-gaap Assets
Assets
296447000 USD
CY2020Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
16467000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
408000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103118000 USD
CY2020Q4 us-gaap Assets
Assets
260832000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
42896000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
51426000 USD
CY2021Q2 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
15939000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
984000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
59243000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
68877000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20000000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20000000 USD
CY2021Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
36197000 USD
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1439000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3188000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
116879000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
132766000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36560000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36560000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35928000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35928000 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
37000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
36000 USD
CY2021Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
88520000 USD
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
88520000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1062426000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1062220000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-971415000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1022710000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
179568000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
128066000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
296447000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
260832000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34196000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16655000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67819000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56984000 USD
CY2021Q2 us-gaap Results Of Operations Production Or Lifting Costs
ResultsOfOperationsProductionOrLiftingCosts
9232000 USD
CY2020Q2 us-gaap Results Of Operations Production Or Lifting Costs
ResultsOfOperationsProductionOrLiftingCosts
8698000 USD
CY2020Q2 us-gaap Results Of Operations Production Or Lifting Costs
ResultsOfOperationsProductionOrLiftingCosts
8698000 USD
us-gaap Results Of Operations Production Or Lifting Costs
ResultsOfOperationsProductionOrLiftingCosts
17186000 USD
us-gaap Results Of Operations Production Or Lifting Costs
ResultsOfOperationsProductionOrLiftingCosts
24340000 USD
CY2021Q2 us-gaap Production Tax Expense
ProductionTaxExpense
2534000 USD
CY2020Q2 us-gaap Production Tax Expense
ProductionTaxExpense
1854000 USD
CY2020Q2 us-gaap Production Tax Expense
ProductionTaxExpense
1854000 USD
us-gaap Production Tax Expense
ProductionTaxExpense
4710000 USD
us-gaap Production Tax Expense
ProductionTaxExpense
5053000 USD
CY2021Q2 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
2193000 USD
CY2020Q2 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
13348000 USD
CY2020Q2 us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
13348000 USD
us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
4698000 USD
us-gaap Results Of Operations Depreciation Depletion Amortization And Accretion
ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion
38203000 USD
CY2021Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1475000 USD
CY2020Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1739000 USD
CY2020Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1739000 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
2969000 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
4373000 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
201784000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
201784000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
209754000 USD
CY2021Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2522000 USD
CY2020Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
4314000 USD
CY2020Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
4314000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
4612000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
9797000 USD
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
256000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
444000 USD
us-gaap Restructuring Charges
RestructuringCharges
2310000 USD
us-gaap Restructuring Charges
RestructuringCharges
444000 USD
CY2021Q2 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
0 USD
CY2020Q2 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
1993000 USD
CY2020Q2 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
1993000 USD
us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
49000 USD
us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
5247000 USD
CY2021Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 USD
CY2020Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
2241000 USD
CY2020Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
2241000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
12467000 USD
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2020Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
42000 USD
CY2020Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
42000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
19713000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-78000 USD
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
65000 USD
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-150000 USD
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-150000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
113000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-307000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
18147000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
232041000 USD
us-gaap Costs And Expenses
CostsAndExpenses
16708000 USD
us-gaap Costs And Expenses
CostsAndExpenses
285129000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
16049000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-215386000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
51111000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-228145000 USD
CY2021Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
84000 USD
CY2020Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
447000 USD
CY2020Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
447000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
131000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
1084000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
287000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
58000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
315000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
58000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
134000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
203000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-389000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
184000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-950000 USD
CY2021Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
16252000 USD
CY2020Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-215775000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
51295000 USD
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-229095000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-646000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
16252000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-215779000 USD
us-gaap Net Income Loss
NetIncomeLoss
51295000 USD
us-gaap Net Income Loss
NetIncomeLoss
-228449000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.42
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.42
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36416000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35611000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35611000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36187000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35581000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37345000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35611000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35611000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37283000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35581000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
128066000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
236000 USD
CY2021Q1 sd Stock Issued During Period Value Warrants
StockIssuedDuringPeriodValueWarrants
0 USD
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
19000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
35043000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
163326000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
584000 USD
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
594000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
16252000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
179568000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
402452000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
185000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-12670000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
389966000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
583000 USD
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-215779000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
174769000 USD
us-gaap Net Income Loss
NetIncomeLoss
51295000 USD
us-gaap Net Income Loss
NetIncomeLoss
-228449000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
283000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7667000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
42576000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
209754000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
36000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
318000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
12467000 USD
sd Payments For Proceeds From Derivative Instruments Operating Activities
PaymentsForProceedsFromDerivativeInstrumentsOperatingActivities
0 USD
sd Payments For Proceeds From Derivative Instruments Operating Activities
PaymentsForProceedsFromDerivativeInstrumentsOperatingActivities
-10577000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
19713000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-78000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
799000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
749000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
71000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
68000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
6945000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
10025000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33231000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
13462000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4389000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6814000 USD
sd Payments To Acquire Assets Asset Acquisitions
PaymentsToAcquireAssetsAssetAcquisitions
3545000 USD
sd Payments To Acquire Assets Asset Acquisitions
PaymentsToAcquireAssetsAssetAcquisitions
0 USD
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
59000 USD
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
37900000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1506000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
29907000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5308000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
39000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
37500000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
122000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
694000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
81000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
613000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-795000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
805000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
62343000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8959000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28266000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5968000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90609000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14927000 USD
us-gaap Interest Paid Net
InterestPaidNet
-106000 USD
us-gaap Interest Paid Net
InterestPaidNet
-812000 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
0 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
616000 USD
sd Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
1260000 USD
sd Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
704000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
363000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
67000 USD
sd Carrying Value Of Property Exchanged In Transaction
CarryingValueOfPropertyExchangedInTransaction
0 USD
sd Carrying Value Of Property Exchanged In Transaction
CarryingValueOfPropertyExchangedInTransaction
3890000 USD
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
Interim Financial Statements. The accompanying unaudited condensed consolidated financial statements and notes should be read in conjunction with the audited financial statements and notes contained in the Company’s 2020 Form 10-K. Certain information and disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted, although the Company believes that the disclosures contained herein are adequate to make the information presented not misleading. In the opinion of management, the financial statements include all adjustments, which consist of normal recurring adjustments unless otherwise disclosed, necessary to fairly state the Company’s unaudited condensed consolidated financial statements.
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The more significant areas requiring the use of assumptions, judgments and estimates include: oil, natural gas and natural gas liquids (“NGL”) reserves; impairment tests of long-lived assets; the carrying value of unproved oil and natural gas properties; depreciation, depletion and amortization; asset retirement obligations; determinations of significant alterations to the full cost pool and related estimates of fair value used to allocate the full cost pool net book value to divested properties, as necessary; valuation allowances for deferred tax assets; income taxes; valuation of derivative instruments; contingencies; and accrued revenue and related receivables. Although management believes the estimates used in the areas noted above are reasonable, actual results could differ significantly from those estimates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Going Concern Consideration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> The accompanying condensed consolidated financial statements are prepared in accordance with GAAP generally accepted accounting principles applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></div>
CY2021Q2 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1439904000 USD
CY2020Q4 us-gaap Capitalized Costs Proved Properties
CapitalizedCostsProvedProperties
1463950000 USD
CY2021Q2 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
13365000 USD
CY2020Q4 us-gaap Capitalized Costs Of Unproved Properties Excluded From Amortization Cumulative
CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationCumulative
17964000 USD
CY2021Q2 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
1453269000 USD
CY2020Q4 us-gaap Oil And Gas Property Full Cost Method Gross
OilAndGasPropertyFullCostMethodGross
1481914000 USD
CY2021Q1 sd Tax Benefits Preservation Plan Change In Beneficial Ownership Period
TaxBenefitsPreservationPlanChangeInBeneficialOwnershipPeriod
P3Y
CY2021Q2 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
1370544000 USD
CY2020Q4 us-gaap Capitalized Costs Accumulated Depreciation Depletion Amortization And Valuation Allowance For Relating To Oil And Gas Producing Activities
CapitalizedCostsAccumulatedDepreciationDepletionAmortizationAndValuationAllowanceForRelatingToOilAndGasProducingActivities
1375692000 USD
CY2021Q2 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
82725000 USD
CY2020Q4 us-gaap Oil And Gas Property Full Cost Method Net
OilAndGasPropertyFullCostMethodNet
106222000 USD
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
319000 USD
CY2020Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
1051000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
127544000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
128236000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
27972000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
25118000 USD
CY2021Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
99572000 USD
CY2020Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
103118000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
182297000 USD
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
209340000 USD
CY2021Q1 sd Tax Benefits Preservation Plan Beneficial Ownership Rights Non Exercisable Increase In Number Of Shares
TaxBenefitsPreservationPlanBeneficialOwnershipRightsNonExercisableIncreaseInNumberOfShares
1 shares
CY2021Q2 sd Commodity Price Used In Calculation Of Full Cost Ceiling
CommodityPriceUsedInCalculationOfFullCostCeiling
49.78
CY2021Q1 sd Stock Acquisition Acquiring Entity Flip Over Event Exercisable Common Stock Rights Times Exercise Price
StockAcquisitionAcquiringEntityFlipOverEventExercisableCommonStockRightsTimesExercisePrice
2 swap
CY2021Q1 sd Stock Acquisition Acquiring Entity Flip Over Event Transfer Threshold Of Assets Cash Flow Or Earning Power Percent
StockAcquisitionAcquiringEntityFlipOverEventTransferThresholdOfAssetsCashFlowOrEarningPowerPercent
50
CY2021Q2 sd Commodity Price Used In Calculation Of Full Cost Ceiling
CommodityPriceUsedInCalculationOfFullCostCeiling
2.43 MMcf
CY2021Q2 sd Asset Impairment Charges Full Cost Ceiling Limitation
AssetImpairmentChargesFullCostCeilingLimitation
0 USD
sd Asset Impairment Charges Full Cost Ceiling Limitation
AssetImpairmentChargesFullCostCeilingLimitation
0 USD
CY2020Q2 sd Asset Impairment Charges Full Cost Ceiling Limitation
AssetImpairmentChargesFullCostCeilingLimitation
201800000 USD
sd Asset Impairment Charges Full Cost Ceiling Limitation
AssetImpairmentChargesFullCostCeilingLimitation
209800000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67800000 USD
us-gaap Results Of Operations Production Or Lifting Costs
ResultsOfOperationsProductionOrLiftingCosts
17200000 USD
us-gaap Production Tax Expense
ProductionTaxExpense
4700000 USD
srt Production Barrels Of Oil Equivalents1
ProductionBarrelsOfOilEquivalents1
3400000 MMBoe
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16700000 USD
CY2020Q2 us-gaap Results Of Operations Production Or Lifting Costs
ResultsOfOperationsProductionOrLiftingCosts
8700000 USD
CY2020Q2 us-gaap Production Tax Expense
ProductionTaxExpense
1900000 USD
CY2020Q2 srt Production Barrels Of Oil Equivalents1
ProductionBarrelsOfOilEquivalents1
2200000 MMBoe
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
57000000.0 USD
us-gaap Results Of Operations Production Or Lifting Costs
ResultsOfOperationsProductionOrLiftingCosts
24300000 USD
us-gaap Production Tax Expense
ProductionTaxExpense
5100000 USD
srt Production Barrels Of Oil Equivalents1
ProductionBarrelsOfOilEquivalents1
4700000 MMBoe
CY2021Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
19555000 USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
23017000 USD
CY2021Q2 sd Production Payable Current
ProductionPayableCurrent
15645000 USD
CY2020Q4 sd Production Payable Current
ProductionPayableCurrent
15367000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2775000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5640000 USD
CY2021Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
4645000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2020Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
6864000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
234000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
477000 USD
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
42000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
61000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
42896000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
51426000 USD
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000.0 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36600000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36600000 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
100000 shares
CY2021Q1 sd Tax Benefits Preservation Plan Change In Beneficial Ownership Threshold Increase In Ownership Percent
TaxBenefitsPreservationPlanChangeInBeneficialOwnershipThresholdIncreaseInOwnershipPercent
0.0050
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34196000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16655000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67819000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56984000 USD
us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
5247000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2021Q2 us-gaap Severance Costs1
SeveranceCosts1
0 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
0 USD
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number
SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
0 shares
CY2021Q2 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
0 USD
CY2020Q2 us-gaap Severance Costs1
SeveranceCosts1
1993000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
0 USD
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number
SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
0 shares
CY2020Q2 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
1993000 USD
us-gaap Severance Costs1
SeveranceCosts1
32000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
17000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number
SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
0 shares
us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
49000 USD
us-gaap Severance Costs1
SeveranceCosts1
5207000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
40000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number
SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
4000 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
16252000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36416000 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2021Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Restrictive Stock Units
DilutiveSecuritiesEffectOnBasicEarningsPerShareRestrictiveStockUnits
0 USD
CY2021Q2 sd Incremental Common Shares Attributable To Dilutive Effect Of Nonvested Restricted Stock Unit With Forfeitable Dividends
IncrementalCommonSharesAttributableToDilutiveEffectOfNonvestedRestrictedStockUnitWithForfeitableDividends
855000 shares
CY2021Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
CY2021Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
36000 shares
CY2021Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Performance Share Units
DilutiveSecuritiesEffectOnBasicEarningsPerSharePerformanceShareUnits
0 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
0 shares
CY2021Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Call Options And Warrants
DilutiveSecuritiesEffectOnBasicEarningsPerShareCallOptionsAndWarrants
0 USD
CY2021Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2021Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Stock Options
DilutiveSecuritiesEffectOnBasicEarningsPerShareStockOptions
0 USD
CY2021Q2 sd Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
38000 shares
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16252000 USD
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37345000 shares
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-215779000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35611000 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.06
CY2020Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
CY2020Q2 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0 shares
CY2020Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Performance Share Units
DilutiveSecuritiesEffectOnBasicEarningsPerSharePerformanceShareUnits
0 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
0 shares
CY2020Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Call Options And Warrants
DilutiveSecuritiesEffectOnBasicEarningsPerShareCallOptionsAndWarrants
0 USD
CY2020Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2020Q2 sd Dilutive Securities Effect On Basic Earnings Per Share Stock Options
DilutiveSecuritiesEffectOnBasicEarningsPerShareStockOptions
0 USD
CY2020Q2 sd Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0 shares
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-215779000 USD
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35611000 shares
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.06
us-gaap Net Income Loss
NetIncomeLoss
51295000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36187000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.42
sd Dilutive Securities Effect On Basic Earnings Per Share Restrictive Stock Units
DilutiveSecuritiesEffectOnBasicEarningsPerShareRestrictiveStockUnits
0 USD
sd Incremental Common Shares Attributable To Dilutive Effect Of Nonvested Restricted Stock Unit With Forfeitable Dividends
IncrementalCommonSharesAttributableToDilutiveEffectOfNonvestedRestrictedStockUnitWithForfeitableDividends
1019000 shares
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
39000 shares
sd Dilutive Securities Effect On Basic Earnings Per Share Performance Share Units
DilutiveSecuritiesEffectOnBasicEarningsPerSharePerformanceShareUnits
0 USD
us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
0 shares
sd Dilutive Securities Effect On Basic Earnings Per Share Call Options And Warrants
DilutiveSecuritiesEffectOnBasicEarningsPerShareCallOptionsAndWarrants
0 USD
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
sd Dilutive Securities Effect On Basic Earnings Per Share Stock Options
DilutiveSecuritiesEffectOnBasicEarningsPerShareStockOptions
0 USD
sd Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
38000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
51295000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37283000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.38
us-gaap Net Income Loss
NetIncomeLoss
-228449000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35581000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.42
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0 shares
sd Dilutive Securities Effect On Basic Earnings Per Share Performance Share Units
DilutiveSecuritiesEffectOnBasicEarningsPerSharePerformanceShareUnits
0 USD
us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
0 shares
sd Dilutive Securities Effect On Basic Earnings Per Share Call Options And Warrants
DilutiveSecuritiesEffectOnBasicEarningsPerShareCallOptionsAndWarrants
USD
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
shares
sd Dilutive Securities Effect On Basic Earnings Per Share Stock Options
DilutiveSecuritiesEffectOnBasicEarningsPerShareStockOptions
0 USD
sd Incremental Common Shares Attributable To Dilutive Effect Of Stock Options
IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions
0 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-228449000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35581000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.42

Files In Submission

Name View Source Status
0001628280-21-016607-index-headers.html Edgar Link pending
0001628280-21-016607-index.html Edgar Link pending
0001628280-21-016607.txt Edgar Link pending
0001628280-21-016607-xbrl.zip Edgar Link pending
ex311ceo302certification06.htm Edgar Link pending
ex312cfo302certification06.htm Edgar Link pending
ex321section906certificati.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sd-20210630.htm Edgar Link pending
sd-20210630.xsd Edgar Link pending
sd-20210630_cal.xml Edgar Link unprocessable
sd-20210630_def.xml Edgar Link unprocessable
sd-20210630_g1.jpg Edgar Link pending
sd-20210630_htm.xml Edgar Link completed
sd-20210630_lab.xml Edgar Link unprocessable
sd-20210630_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending